Christopher A Marlett - Net Worth and Insider Trading
Christopher A Marlett Net Worth
The estimated net worth of Christopher A Marlett is at least $2 Million dollars as of 2024-05-26. Christopher A Marlett is the Director of Cue Biopharma Inc and owns about 768,503 shares of Cue Biopharma Inc (CUE) stock worth over $1 Million. Christopher A Marlett is the 10% Owner of ClearSign Technologies Corp and owns about 363,780 shares of ClearSign Technologies Corp (CLIR) stock worth over $327,402. Christopher A Marlett is also the Director, 10% Owner of The Arena Group Holdings Inc and owns about 137,878 shares of The Arena Group Holdings Inc (AREN) stock worth over $117,196. Details can be seen in Christopher A Marlett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher A Marlett has not made any transactions after 2019-12-31 and currently still holds the listed stock(s).
Transaction Summary of Christopher A Marlett
Christopher A Marlett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher A Marlett owns 5 companies in total, including Cue Biopharma Inc (CUE) , The Arena Group Holdings Inc (AREN) , and ClearSign Technologies Corp (CLIR) among others .
Click here to see the complete history of Christopher A Marlett’s form 4 insider trades.
Insider Ownership Summary of Christopher A Marlett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2019-12-31 | director |
| AREN | The Arena Group Holdings Inc | 2017-12-05 | director & 10 percent owner & Chief Executive Officer |
| CLIR | ClearSign Technologies Corp | 2012-04-24 | 10 percent owner |
 | | 2004-12-17 | director & 10 percent owner |
| | 2023-07-25 | director & 10 percent owner & CEO |
Christopher A Marlett Latest Holdings Summary
Christopher A Marlett currently owns a total of 3 stocks. Among these stocks, Christopher A Marlett owns 768,503 shares of Cue Biopharma Inc (CUE) as of December 31, 2019, with a value of $1 Million and a weighting of 73.75%. Christopher A Marlett owns 363,780 shares of ClearSign Technologies Corp (CLIR) as of April 24, 2012, with a value of $327,402 and a weighting of 19.33%. Christopher A Marlett also owns 137,878 shares of The Arena Group Holdings Inc (AREN) as of December 5, 2017, with a value of $117,196 and a weighting of 6.92%.
Latest Holdings of Christopher A Marlett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2019-12-31 | 768,503 | 1.63 | 1,248,817 |
| CLIR | ClearSign Technologies Corp | 2012-04-24 | 363,780 | 0.90 | 327,402 |
| AREN | The Arena Group Holdings Inc | 2017-12-05 | 137,878 | 0.85 | 117,196 |
Holding Weightings of Christopher A Marlett
Christopher A Marlett Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher A Marlett has made a total of 3 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cue Biopharma Inc is the sale of 24,700 shares on December 31, 2019, which brought Christopher A Marlett around $402,116.
According to the SEC Form 4 filings, Christopher A Marlett has made a total of 0 transactions in ClearSign Technologies Corp (CLIR) over the past 5 years. The most-recent trade in ClearSign Technologies Corp is the sale of 0 shares on April 24, 2012, which brought Christopher A Marlett around $0.
According to the SEC Form 4 filings, Christopher A Marlett has made a total of 0 transactions in The Arena Group Holdings Inc (AREN) over the past 5 years. The most-recent trade in The Arena Group Holdings Inc is the acquisition of 1,401 shares on December 5, 2017, which cost Christopher A Marlett around $43,779.
Insider Trading History of Christopher A Marlett
- 1
Christopher A Marlett Trading Performance
GuruFocus tracks the stock performance after each of Christopher A Marlett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher A Marlett is 57.19%. GuruFocus also compares Christopher A Marlett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher A Marlett within 3 months outperforms 10 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher A Marlett's insider trading performs compared to the benchmark.
Performance of Christopher A Marlett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.72 | | | | | |
| Relative Return to S&P 500(%) | 16.62 | | | | | |
Christopher A Marlett Ownership Network
Christopher A Marlett Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Christopher A Marlett is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Christopher A Marlett made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net sale of 9,325 shares made by Peter A Kiener , a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,325 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 2,325 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Christopher A Marlett Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher A Marlett. You might contact Christopher A Marlett via mailing address: 100 Wilshire Blvd, Santa Monica Ca 90401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
